Antisense compounds, compositions and methods are provided for modulating
the expression of MyD88. The compositions comprise antisense compounds, particularly
antisense oligonucleotides, targeted to nucleic acids encoding MyD88. Methods of
using these compounds for modulation of MyD88 expression and for treatment of diseases
associated with expression of MyD88 are provided.